personalized medicine

July 9, 2015

VUMC lands major pharmacogenomics grant

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given.

By Bill Snyder
AIDS ribbon on the globe
June 25, 2015

VUMC, Meharry and State Health Department receive NIH grant to establish AIDS research center

Vanderbilt University has received a five-year grant from the National Institutes of Health (NIH) to establish the Tennessee Center for AIDS Research with Meharry Medical College and the Tennessee Department of Health.

By Bill Snyder
May 7, 2015

Event showcases Vanderbilt’s personalized medicine efforts

More than 100 clinician-scientists, geneticists, biomedical informatics experts, bio-statisticians, policy experts and students gathered for Personalized Medicine Day on May 1 at the Student Life Center. The depth and breadth of Vanderbilt’s ongoing investment in personalized medicine was on display in lectures, panel discussions and poster sessions.

By Paul Govern
April 23, 2015

Day of events to explore personalized medicine

Vanderbilt faculty and staff are invited to attend Personalized Medicine Day on Friday, May 1, 8 a.m. to 4 p.m. at the Vanderbilt University Student Life Center.

By Paul Govern
April 2, 2015

VUMC’s Denny named to NIH precision medicine group

Josh Denny, M.D., M.S., associate professor of Biomedical Informatics and Medicine, will help guide planning for the precision medicine initiative announced by President Obama in his January State of the Union Address.

By Paul Govern
February 19, 2015

Workshop explores President’s Precision Medicine Initiative

The Precision Medicine Initiative is a national effort announced by President Obama during his State of the Union address to provide more effective treatment and prevention strategies for individuals by taking into account their unique genetic, environmental and lifestyle factors.

By Bill Snyder
January 29, 2015

Core facilities key driver of VUMC research gains

During the past five years, Vanderbilt University Medical Center has become a leader in “personalized medicine,” the use of genomic information to individualize patient care.
By Bill Snyder
June 12, 2014

Roden named to NIH’s genomics advisory council

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH).
By Bill Snyder
April 30, 2014

Potential mechanism for myeloma drug’s variable toxicity

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.
By Leigh MacMillan
March 31, 2014

E-records shed light on drug response

Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response.
By Leigh MacMillan
August 15, 2013

Transplant drug added to PREDICT program

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.
By Bill Snyder
March 14, 2013

Recruitments bolster personalized medicine initiative

VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools.
By Nancy Humphrey
March 1, 2013

Zeppos reflects on first five years as chancellor

The One Vanderbilt transformation continues as Nicholas S. Zeppos marks five years as chancellor. Read the story and watch video of Zeppos discussing the opportunities and challenges facing Vanderbilt today.
By VUMC News and Communications
1 2 3 4 5